— Know what they know.
Not Investment Advice

MRUS Earnings

Merus N.V.
1W: -7.1% 1M: -6.2% 3M: -4.4% 1Y: +113.9% 3Y: +513.5% 5Y: +390.2%
$90.00
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $6.8B mcap · 70M float · 2.45% daily turnover · Short 55% of daily vol
Last Earnings 2025-10-31
EPS
€-1.23 (US$-1.38)
▲ Beat +0.0%
Revenue
€10M ($12M)
▲ Beat +15.8%
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
€-1.34 (US$-1.51)
Range: €-1.73 - €-0.90
Revenue Estimate
€10M ($12M)
1 analysts
1 USD = 0.89 EUR

Estimate vs Actual

Earnings Surprise History

10/20
EPS Beats
13/20
Revenue Beats
50%
EPS Beat Rate
65%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-01-13 quarter 2026-09-30 €-1.23 €-1.23 — €12,130,335 €12,129,250
2026-01-13 annual 2029-12-31 €5.36 €5.36 — €1,438,445,693 €1,438,317,118
2026-01-13 quarter 2025-12-30 €-1.11 €-1.11 — €9,961,319 €9,960,429
2026-01-13 annual 2026-12-31 €-4.93 €-4.93 — €57,942,839 €57,937,660
2026-01-13 quarter 2026-03-30 €-1.35 €-1.35 — €11,363,070 €11,362,054
2026-01-13 quarter 2027-09-30 €-0.91 €-0.91 — €7,394,727 €7,394,066
2026-01-13 annual 2027-12-31 €-3.74 €-3.74 — €221,522,882 €221,503,081
2026-01-13 quarter 2026-06-30 €-1.34 €-1.34 — €11,274,744 €11,273,737
2026-01-13 quarter 2027-12-30 €-0.95 €-0.95 — €7,648,698 €7,648,015
2026-01-13 quarter 2026-12-30 €-1.34 €-1.34 — €10,432,946 €10,432,014
2026-01-13 annual 2025-12-31 €-5.67 €-5.67 — €62,913,266 €62,907,643
2026-01-13 annual 2028-12-31 €0.17 €0.17 — €691,802,583 €691,740,746
2026-01-13 quarter 2027-06-30 €-0.88 €-0.88 — €7,009,950 €7,009,323
2026-01-13 quarter 2027-03-30 €-0.87 €-0.87 — €6,755,978 €6,755,374
2026-01-12 quarter 2027-12-30 €-0.95 €-0.95 — €7,654,265 €7,648,698
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms